ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
02/19/2026
Back to search
Official data from USPTO
EVAXION
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
EVAXION
ST13
US500000079342587Class
5, 9, 42
Filing
79342587
Registration
7147508
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
02/20/2026
Classification
Registered
Trademark type
Word
Nice classes
5, 9, 42
Filing date
02/10/2022
Registration date
08/29/2023
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/29/2023
Last transaction
02/20/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
98
Owner location
DK
Examiner
DUENAS, TAYLOR S
Law office
N80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Evaxion A/S
EVAXION BIOTECH A/S
Representatives
Michael R. Rizzo Saunders & Silverstein LLP
Technical classification
Nice Classes
Class 5Class 9Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceuticals and medical preparations for treating cancer and infectious diseases; medicine for treatment of cancer; pharmaceuticals preparations and substances for the treatment of cancerviral diseasesallergyautoimmune diseasesmicrobiota dysbiosisparasites; biopharmaceuticals for the treatment of cancerviral diseasesallergyautoimmune diseasesmicrobiota dysbiosisparasites; immunotherapy preparations for treating cancer and infectious diseases; monoclonal antibodies (mAb) for medical purposes; vaccines for human use; viral vaccines; vaccine adjuvants; cells for medical use
Class 9
Downloadable software for design of pharmaceuticals; downloadable artificial intelligence software for design of pharmaceuticals; downloadable artificial intelligence and machine learning software for design of pharmaceuticals; downloadable artificial intelligence software platforms for design of pharmaceuticals; downloadable software for evaluating medical treatment options and treatment outcomes for cancer; downloadable software for design and development of immunotherapy; downloadable software and downloadable artificial intelligence software for identifying antigens and epitopes; downloadable software and downloadable artificial intelligence software for designing and developing vaccines and medicines; downloadable software and downloadable artificial intelligence software for designing pharmaceuticals for cancerviral diseasesallergyautoimmune diseasesmicrobiota dysbiosis and parasites
Class 42
Scientific and technological research services in the field of oncologyinfectious diseasesimmunology; scientific research and development services in the fields of immunology and oncology; decoding of data; research and development of pharmaceuticals; medical and pharmacological research services; clinical medical research in the field of oncologyinfectious diseasesimmunology; research and development of vaccines and medicines; scientific and technological research relating to virusoncologyautoimmune diseases; scientific and technological research relating to allergies
Publications
History of USPTO decisions and trademark events.
33 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
04/24/2025
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
02/01/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/01/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/01/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/01/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/26/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/04/2023
FIMP
FINAL DISPOSITION PROCESSED
12/04/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/29/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/29/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
08/29/2023
GPNX
NOTIFICATION PROCESSED BY IB
06/13/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/13/2023
PUBO
PUBLISHED FOR OPPOSITION
06/13/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/24/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
05/24/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/24/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/10/2023
DOCK
ASSIGNED TO EXAMINER
05/10/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/04/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/03/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/03/2023
RFNT
REFUSAL PROCESSED BY IB
02/21/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/27/2023
RFRR
REFUSAL PROCESSED BY MPU
01/27/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/30/2022
CNRT
NON-FINAL ACTION WRITTEN
11/29/2022
DOCK
ASSIGNED TO EXAMINER
11/26/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
09/18/2022
MAFR
APPLICATION FILING RECEIPT MAILED
06/21/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/17/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/16/2022
Continuous trademark protection
Get notified about every new filing that threatens EVAXION or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.